全文获取类型
收费全文 | 2714篇 |
免费 | 76篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 30篇 |
妇产科学 | 27篇 |
基础医学 | 357篇 |
口腔科学 | 43篇 |
临床医学 | 118篇 |
内科学 | 845篇 |
皮肤病学 | 30篇 |
神经病学 | 214篇 |
特种医学 | 151篇 |
外科学 | 394篇 |
综合类 | 6篇 |
预防医学 | 73篇 |
眼科学 | 32篇 |
药学 | 131篇 |
中国医学 | 10篇 |
肿瘤学 | 356篇 |
出版年
2021年 | 25篇 |
2020年 | 20篇 |
2019年 | 29篇 |
2018年 | 31篇 |
2017年 | 24篇 |
2016年 | 46篇 |
2015年 | 49篇 |
2014年 | 77篇 |
2013年 | 75篇 |
2012年 | 140篇 |
2011年 | 180篇 |
2010年 | 95篇 |
2009年 | 86篇 |
2008年 | 150篇 |
2007年 | 179篇 |
2006年 | 173篇 |
2005年 | 200篇 |
2004年 | 186篇 |
2003年 | 173篇 |
2002年 | 182篇 |
2001年 | 41篇 |
2000年 | 27篇 |
1999年 | 48篇 |
1998年 | 47篇 |
1997年 | 50篇 |
1996年 | 40篇 |
1995年 | 33篇 |
1994年 | 27篇 |
1993年 | 36篇 |
1992年 | 28篇 |
1991年 | 19篇 |
1990年 | 20篇 |
1989年 | 23篇 |
1988年 | 13篇 |
1987年 | 22篇 |
1986年 | 15篇 |
1985年 | 14篇 |
1984年 | 19篇 |
1983年 | 14篇 |
1981年 | 14篇 |
1980年 | 12篇 |
1979年 | 10篇 |
1978年 | 15篇 |
1977年 | 12篇 |
1976年 | 11篇 |
1975年 | 8篇 |
1974年 | 12篇 |
1973年 | 9篇 |
1972年 | 14篇 |
1970年 | 10篇 |
排序方式: 共有2822条查询结果,搜索用时 265 毫秒
41.
42.
We investigated the correlation between clinical severity and striatal [123I]-CIT binding in 12 patients with Parkinson's Disease (PD: 6 men and 6 women, age: 65 +/- 7 years, Hoehn & Yahr stage: 1 to 3). The clinical severity of PD patients was measured with the Unified Parkinson's Disease Rating Scale (UPDRS) after withdrawal of antiparkinsonian medication at least 12 hours before assessment. [123I]beta-CIT binding in the caudate and putamen was measured at 3 hours [V'3 (day 1)], and at 24 hours [V'3 (day 2)) after tracer injection with small square ROIs. The specific striatal uptake index (day 2) was calculated with large square ROIs that encompassed the whole striatum. The best correlation (r = -0.82, p < 0.0012) was between putamenal V'3 (day 2) and the motor UPDRS scores. When the motor UPDRS scores were divided into four subscales, bradykinesia was the only sign that correlated significantly with putamenal V'3 (day 2) (r = -0.81, p < 0.002). [123I]beta-CIT SPECT is a useful marker of disease severity in PD with potential utility in the serial monitoring of disease progression. 相似文献
43.
Shigeo Koido Eiichi Hara Sadamu Homma Akira Torii Yoichi Toyama Hidejiro Kawahara Michiaki Watanabe Katsuhiko Yanaga Kiyotaka Fujise Hisao Tajiri Jianlin Gong Gotaro Toda 《Clinical cancer research》2005,11(21):7891-7900
The aim of antitumor immunotherapy is to induce CTL responses against autologous tumors. Previous work has shown that fusion of human dendritic cells and autologous tumor cells induce CTL responses against autologous tumor cells in vitro. However, in the clinical setting of patients with colorectal carcinoma, a major difficulty is the preparation of sufficient amounts of autologous tumor cells. In the present study, autologous dendritic cells from patients with colorectal carcinoma were fused to allogeneic colorectal tumor cell line, COLM-6 (HLA-A2(-)/HLA-24(-)), carcinoembryonic antigen (CEA)(+), and MUC1(+) as an alternative strategy to deliver shared colorectal carcinoma antigens to dendritic cells. Stimulation of autologous T cells by the fusion cells generated with autologous dendritic cells (HLA-A2(+) and/or HLA-A24(+)) and allogeneic COLM-6 resulted in MHC class I- and MHC class II-restricted proliferation of CD4(+) and CD8(+) T cells, high levels of IFN-gamma production in both CD4(+) and CD8(+) T cells, and the simultaneous induction of CEA- and MUC1-specific CTL responses restricted by HLA-A2 and/or HLA-A24. Finally, CTL induced by dendritic cell/allogeneic COLM-6 fusion cells were able to kill autologous colorectal carcinoma by HLA-A2- and/or HLA-A24-restricted mechanisms. The demonstration of CTL activity against shared tumor-associated antigens using an allogeneic tumor cell line, COLM-6, provides that the presence of alloantigens does not prevent the development of CTL with activity against autologous colorectal carcinoma cells. The fusion of allogeneic colorectal carcinoma cell line and autologous dendritic cells could have potential applicability to the field of antitumor immunotherapy through the cross-priming against shared tumor antigens and provides a platform for adoptive immunotherapy. 相似文献
44.
45.
Tsubasa Hiraki Miho Hatanaka Akiko Arimura Hisao Kawahira Mari Kirishima Ikumi Kitazono Michiko Horinouchi Michiyo Higashi Takuro Kanekura Akihide Tanimoto 《Journal of cutaneous pathology》2020,47(2):154-160
Nivolumab and pembrolizumab are humanized IgG4 monoclonal antibodies against programmed cell death 1 (PD-1). Although these agents are effective in treating advanced melanoma, non-small-cell lung carcinoma, and other types of cancers, various adverse events have been reported. Cutaneous adverse events are particularly prevalent and, while granulomatous/sarcoid-like reactions are uncommon, they are increasingly recognized as immune-related adverse events associated with immune checkpoint inhibitors. Herein, we report two cases of granulomatous/sarcoid-like reaction with foreign material, mimicking metastatic malignancy after PD-1 inhibitor treatment. Clinicians should be aware of the existence of cutaneous lesions and perform biopsy if needed to prevent misdiagnosis and unnecessary adjustments to immunotherapy. 相似文献
46.
47.
48.
Kensaku Yamaga Kohei Shomori Hideki Yamashita Koji Endo Chikako Takeda Takeshi Minamizaki Haruhiko Yoshida Ryota Teshima Hisao Ito 《The Journal of dermatology》2014,41(2):163-167
Proliferative fasciitis (PF) is a benign, discrete proliferation of fibroblasts or myofibroblasts in soft tissue. Proliferative fasciitis mostly occurs in adults and is often confused with a sarcoma because of its rapid growth and peculiar histological features. We report a case of PF mimicking a sarcoma which developed in a 13‐year‐old boy, who noticed a painful tumor, with gradual enlargement, in his right lower leg. Magnetic resonance imaging revealed that the tumor measured 34 mm × 20 mm × 41 mm and was located in the subcutaneous tissue. The tumor was surgically resected. Pathologically, the tumor was composed of a proliferation of atypical spindle cells, admixed with larger ganglion‐like cells. Immunohistochemically, the tumor cells were positive for vimentin, cytokeratin, smooth muscle actin, HHF‐35 and Fli‐1. The tumor was subsequently diagnosed as a PF, although it was difficult to differentiate from a sarcoma. Five years after surgery, the postoperative course has been uneventful with no recurrence or metastasis. 相似文献
49.
50.